Patents by Inventor Jagannadha K. Sastry

Jagannadha K. Sastry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
    Patent number: 7659071
    Abstract: The present invention concerns the use of E6 and/or E7 peptides from human papilloma virus (HPV) to evaluate a cell-mediated response in a patient infected with HPV to determine the prognosis for that patient with respect to the development or recurrence of pre-cancerous or cancerous growths, including cervical intraepithelial neoplasia (CIN).
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: February 9, 2010
    Assignee: Board of Regents, the University of Texas System
    Inventors: Jagannadha K. Sastry, Guillermo Tortolero-Luna, Michele Follen
  • METHODS AND COMPOSITIONS RELATING TO HPV-ASSOCIATED PRE-CANCEROUS AND CANCEROUS GROWTHS, INCLUDING CIN
    Publication number: 20090053296
    Abstract: The present invention concerns the use of E6 and/or E7 peptides from human papilloma virus (HPV) to evaluate a cell-mediated response in a patient infected with HPV to determine the prognosis for that patient with respect to the development or recurrence of pre-cancerous or cancerous growths, including cervical intraepithelial neoplasia (CIN).
    Type: Application
    Filed: July 11, 2008
    Publication date: February 26, 2009
    Inventors: Jagannadha K. Sastry, Guillermo Tortolero-Luna, Michele Follen
  • Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
    Patent number: 7410758
    Abstract: The present invention concerns the use of E6 and/or E7 peptides from human papilloma virus (HPV) to evaluate a cell-mediated response in a patient infected with HPV to determine the prognosis for that patient with respect to the development or recurrence of pre-cancerous or cancerous growths, including cervical intraepithelial neoplasia (CIN).
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: August 12, 2008
    Assignee: Board of Regents, the University of Texas System
    Inventors: Jagannadha K. Sastry, Guillermo Tortolero-Luna, Michele Follen
  • Compositions and methods for eliciting immune or anti-infective responses
    Patent number: 7319000
    Abstract: Disclosed are compositions and methods for the prevention and treatment of viral infections. The identification of distinct classes of peptides for use in both anti-viral vaccines and therapeutic formulations is reported. Peptide formulations are disclosed which enhance the systemic distribution, activity, and longevity of anti-viral cytotoxic T cells, and/or which protect human cells from HIV infection.
    Type: Grant
    Filed: June 5, 1997
    Date of Patent: January 15, 2008
    Assignee: Board of Regents, the University of Texas System
    Inventors: Jagannadha K. Sastry, Ralph B. Arlinghaus, Chris D. Platsoucas, Pramod N. Nehete
  • Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
    Patent number: 6210873
    Abstract: The present invention discloses a novel method for the rapid screening of candidate cytotoxic T lymphocyte- (CTL-) inducing compounds, such as peptides, by the in vivo priming of CTLs with synthetic peptides. The use of compounds so identified for the development of CTL vaccines for the treatment of various infectious disorders, including the treatment of viral diseases such as AIDS, herpes, influenza, and feline or bovine leukemia, is also disclosed, as is the use of this methodology for the preparation of specifically primed CTLs.
    Type: Grant
    Filed: December 2, 1991
    Date of Patent: April 3, 2001
    Assignee: Board of Regents, The University of Texas System
    Inventors: Jagannadha K. Sastry, Ralph B. Arlinghaus, Chris D. Platsoucas